相关实验视频

Updated: May 10, 2025

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

目标DLL3:瘤治疗的创新策略

Hui Wang^1,2,3,4, Tong Zheng^1,2,3,4, Dan Xu^1,4

¹Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China.

|April 26, 2025

概括

针对Delta-like 3 (DLL3) 显示出癌症治疗的前景,特别是小细胞肺癌. 研究探索DLL3疗法,解决耐药性和异质性等挑战,以改善患者的治疗结果.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫治疗是一种免疫疗法.

背景情况:

德尔塔样3 (DLL3) 是一种在各种癌症中过度表达的致癌蛋白,特别是小细胞肺癌.
DLL3通过Notch信号通路在瘤发生和癌症进展中发挥作用.

研究的目的:

审查针对DLL3进行癌症治疗的现有和新兴疗法.
探索DLL3向癌症治疗中的机制,挑战和未来的机会.

主要方法:

对DLL3向治疗的临床前和临床数据的审查.
对DLL3生物特征及其在癌症中的作用的分析.
评估治疗方法,包括抗体与药物合物,T细胞诱导剂,CAR T细胞和放射性药物治疗.

主要成果:

针对DLL3的治疗方法显示出前临床和临床疗效的前景.
目前的方法包括抗体-药物合物,T细胞参与剂,CAR T细胞和放射性药物治疗.
挑战包括瘤异质性,耐药性和患者分层.

结论:

针对DLL3的疗法为癌症提供了新的治疗选择,有可能彻底改变治疗.
组合疗法,创新药物输送和正在进行的临床试验是优化DLL3向策略的关键.
多学科研究对于推进DLL3向癌症治疗的临床应用至关重要.

关键词:

在 DLL3 中,你会看到 DLL3 文件.临床试验是指临床试验中的临床试验.固体瘤是一个固体瘤.有针对性的治疗.

更多相关视频

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.